Abstract: Method for controlling a sheet feeding device (1) comprising an elevator (2) for a stack of sheets, and an air supply system (3) configured to supply and direct one of more air streams towards an upper region (4) of the sheet feeding device for floating a plurality of upper sheets of the stack of sheets, wherein the elevator comprises a vertically movable support (5) for supporting the stack of sheets from below, wherein the sheet feeding device comprises an optical sensor (6) positioned adjacent the floated sheets for measuring light reflected from the floated sheets at a plurality of different heights, wherein the method comprises the steps of: continuously deriving from the optical sensor a density reading (DR) indicating the density of sheets floated, continuously deriving an average density (AD) based on a plurality of density readings, continuously deriving an upper density limit (UDL) based on the average density multiplied by a predetermined upper density limit factor (UDLF), continuously deriving a l

Abstract: Method for controlling a sheet feeding device (1) comprising an elevator (2) for a stack of sheets, and an air supply system (3) configured to supply and direct one of more air streams towards an upper region (4) of the sheet feeding device for floating a plurality of upper sheets of the stack of sheets, wherein the elevator comprises a vertically movable support (5) for supporting the stack of sheets from below, wherein the sheet feeding device comprises an optical sensor (6) positioned adjacent the floated sheets pot for measuring light reflected from the floated sheets at a plurality of different heights, wherein the method comprises the steps of: continuously deriving from the optical sensor a density reading (DR) indicating the density of sheets floated, continuously deriving an average density (AD) based on a plurality of density readings, continuously deriving an upper density limit (UDL) based on the average density multiplied by a predetermined upper density limit factor (UDLF), continuously deriving

Abstract: An on-chip balun comprising a primary side, a secondary side, and an integrated notch filter.

Abstract: An on-chip balun comprising a primary side, a secondary side, and an integrated notch filter.

Abstract: Phytol (3,7,11,15-Tetramethyl-2-hexadecen-1-ol),orderivates thereof, of natural or synthetic origin are used as active ingredient in formulations to lower serum levels of triglycerides and/or cholesterol. Phytol can be administered to patients with disease conditions related to increased levels of cholesterol or triglycerides such as type II diabetes, obesity or other patients in risk of cardiovascular diseases due to elevated cholesterol levels. Phytol can also be administered to healthy individuals to maintain normal levels of serum cholesterol.

Abstract: There is provided compounds of formula I, wherein X1 to X4, R1 to R4, Y1, Y2 and L are as defined in the description, and pharmaceutically-acceptable salts thereof, which may be useful in the treatment and/or prophylaxis of autoimmune diseases, inflammatory (e.g. chronic inflammatory) diseases and/or other diseases that may benefit from production of ROS (reactive oxygen species) by a NADPH oxidase complex.

Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.

Abstract: Phytol (3,7,11,15-Tetramethyl-2-hexadecen-1-ol), or derivates thereof, of natural or synthetic origin are used as active ingredient in formulations to lower serum levels of triglycerides and/or cholesterol. Phytol can be administered to patients with disease conditions related to increased levels of cholesterol or triglycerides such as type II diabetes, obesity or other patients in risk of cardiovascular diseases due to elevated cholesterol levels. Phytol can also be administered to healthy individuals to maintain normal levels of serum cholesterol.

Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.

Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.

Abstract: The invention relates to methods and materials involved in treating autoimmune conditions. In particular, the invention relates to methods and compounds (and compositions including the compounds) involved in treating, preventing, or delaying the onset of autoimmune conditions. The compounds include one or more isoprenoid units. The compounds can enhance NADPH oxidase activity.

Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.

Abstract: A method for fabrication of a high-voltage, high-frequency MOS-transistor combines a deep n-well and a p-well process and the formation of an extended drain region (45), and a channel region (31), the channel having a short length and becoming well aligned with the gate edge. The deep n-well (11) and the p-well (19) are both produced by ion implantation. The method is compatible with a standard CMOS process and gives low manufacturing costs, increased breakdown voltage, better overall high-frequency performance, and the prevention of the “body effect” occurring by isolation of the p-well.

Abstract: A method for fabrication of a high-voltage, high-frequency MOS-transistor combines a deep n-well and a p-well process and the formation of an extended drain region (45), and a channel region (31), the channel having a short length and becoming well aligned with the gate edge. The deep n-well (11) and the p-well (19) are both produced by ion implantation. The method is compatible with a standard CMOS process and gives low manufacturing costs, increased breakdown voltage, better overall high-frequency performance, and the prevention of the “body effect” occurring by isolation of the p-well.

Abstract: The invention relates to a method for forming a high voltage NMOS transistor together with a low voltage NMOS transistor and a low voltage PMOS transistor, respectively, in an n-well CMOS process by adding solely two additional process steps to a conventional CMOS process: (i) a masking step, and (ii) an ion implantation step for forming a doped channel region for the high voltage MOS transistor in the substrate self-aligned to the edge of the high voltage MOS transistor gate region. The ion implantation is performed through the mask in a direction, which is inclined at an angle to the normal of the substrate surface, to thereby create the doped channel region partly underneath the gate region of the high voltage MOS transistor.

Abstract: The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in diagnosing arthritis conditions that are accompanied by an NADPH oxidase deficiency, methods and materials involved in treating, preventing, or delaying the onset of arthritis conditions that are accompanied by an NADPH oxidase deficiency, and methods and materials involved in identifying agonists and antagonists of NADPH oxidase activity.

Abstract: The invention relates to a method for forming a high voltage NMOS transistor together with a low voltage NMOS transistor and a low voltage PMOS transistor, respectively, in an n-well CMOS process by adding solely two additional process steps to a conventional CMOS process: (i) a masking step, and (ii) an ion implantation step for forming a doped channel region for the high voltage MOS transistor in the substrate self-aligned to the edge of the high voltage MOS transistor gate region. The ion implantation is performed through the mask in a direction, which is inclined at an angle to the normal of the substrate surface, to thereby create the doped channel region partly underneath the gate region of the high voltage MOS transistor.